From design to validation: IBA’s end-to-end support at CHU Québec - Université Laval
The hospital needed support to set up a radiopharmacy to expand patient access, and to boost its theranostics leadership.
Before setting up an in-house radiopharmacy, the CHU Québec – Université Laval relied on external providers for radiopharmaceuticals. It constrained its ability to provide patient access to novel theranostics radiopharmaceuticals. The Canadian hospital turned to IBA for a solution that could ensure consistent and flexible production while supporting both clinical care and research.
IBA partnered with the CHU Québec to implement the IntegraLab® project with end-to-end support and technical expertise.
IBA has been a comprehensive partner, guiding this hospital from design to installation and validation. By integrating the cyclotron, targets, chemistry modules and hot cells, IBA ensured precise coordination and reliable performance. This collaboration enabled the CHU to build cutting-edge radiopharmacy, strengthening clinical capabilities, and fostering future innovation.
Our journey together
CHU de Québec - Université Laval
-
Phase 1Project conceptionThe production scope and business plan have been collaboratively defined at the start of the project. The facility layout what thought to meet international (c)GMP standards, with safety, waste management, and environmental impact carefully addressed.
-
Phase 2Equipment integrationIBA provided all required equipment for radioisotope production, covering cyclotrons, targets, beam lines and chemistry modules, and ensured seamless integration with complementary systems, such as hot cells and quality control equipment.
-
Phase 3Validation & operationInstallation and operational qualifications for the equipment were carried out in close coordination.
-
Phase 4Optimization & longevityUpgrades, maintenance, and training ensure safe, efficient operation and keep the facility at the forefront of radiopharmaceutical production.
IBA’s expertise and IntegraLab® services ensured seamless integration of all the equipment we need.
"Partnering with IBA on the development of our radiopharmacy, an IntegraLab® project, has been a key experience for the CHU de Québec – Université Laval. From the earliest design discussions to the final phases of installation and validation, IBA provided strong expertise and unwavering support at every stage of the project. Beyond the technical achievements, the quality of the human relationships with the IBA team set this collaboration apart. It transformed a complex and demanding project into a genuinely collaborative and rewarding experience.
The integration of the Cyclone® KIUBE, Nirta® targets, and Synthera® modules required technical excellence and precise coordination. The IBA team met every challenge seamlessly, demonstrating remarkable professionalism even within a high-pressure environment.
Thanks to IBA’s end-to-end support, our facility is now fully equipped to advance radiopharmaceutical production with confidence and reliability. This project establishes a strong foundation for future growth, innovation, and clinical impact in Québec City and beyond."
This IntegraLab® project highlighted IBA’s innovative approach and collaborative support.
"Working on this IntegraLab® project was an exciting opportunity to push the boundaries of radiopharmaceutical production in Canada. From the initial project kick-off to the final validation, we worked in close collaboration with the CHU de Québec – Université Laval."
Discover more about IntegraLab®
Your customized (c)GMP radiopharmacy